Empresa Todos Medical Ltd. Other OTC
Acciones
TOMDF
IL0011392375
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
COVID-19 Testing
100,0
%
| 12 | 100,0 % | 8 | 100,0 % | -37,08 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 12 | 100,0 % | 8 | 100,0 % | -37,08 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 41 | 05/01/20 | |
Daniel Hirsch
DFI | Director of Finance/CFO | 55 | - |
Herman Weiss
CHM | Chairman | 53 | 22/06/17 |
Elise Brownell
CTO | Chief Tech/Sci/R&D Officer | - | 20/07/20 |
Jorge Leon
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/20 |
Richard Galterio
IRC | Investor Relations Contact | 60 | - |
Greg Meiselbach
LAW | General Counsel | - | 08/03/22 |
Valentino Smith
SAM | Sales & Marketing | - | 20/12/21 |
Corporate Officer/Principal | - | 01/03/20 | |
Ilanit Halperin
AUD | Comptroller/Controller/Auditor | 53 | 07/07/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lauren Chung
BRD | Director/Board Member | 48 | 17/04/20 |
Chief Executive Officer | 41 | 05/01/20 | |
Moshe Abramovitz
BRD | Director/Board Member | 80 | 27/02/16 |
Herman Weiss
CHM | Chairman | 53 | 22/06/17 |
Moshe Schlisser
BRD | Director/Board Member | 35 | 27/02/16 |
Daniel Hirsch
DFI | Director of Finance/CFO | 55 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 130 423 853 | 1 966 392 728 ( 92,30 %) | 0 | 92,30 % |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-31,90 % | 9586,32 M | |
-6,25 % | 3210,97 M | |
+25,95 % | 2918,66 M | |
-13,96 % | 2151,24 M | |
-16,83 % | 1788,88 M | |
+72,82 % | 1474,42 M | |
+29,17 % | 770 M | |
-2,62 % | 761 M | |
-26,33 % | 548 M |